719 hedge funds and large institutions have $9.69B invested in GSK in 2015 Q2 according to their latest regulatory filings, with 52 funds opening new positions, 289 increasing their positions, 233 reducing their positions, and 64 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding in top 10

Funds holding in top 10:

more call options, than puts

Call options by funds: $ | Put options by funds: $

less ownership

Funds ownership:

3% less funds holding

Funds holding: 740719 (-21)

17% less capital invested

Capital invested by funds: $11.7B → $9.69B (-$1.97B)

19% less first-time investments, than exits

New positions opened: 52 | Existing positions closed: 64

Holders
719
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
11
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$221M
Puts
$218M
Net Calls
Net Calls Change

Top Buyers

1 +$303M
2 +$75M
3 +$54.4M
4
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
+$41.8M
5
Jane Street
Jane Street
New York
+$34.6M

Top Sellers

1 -$456M
2 -$357M
3 -$172M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$107M
5
Invesco
Invesco
Georgia
-$97.2M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$520M
2
$485M
3
$484M
4
$480M
5
$467M
6
$457M
7
$437M
8
$385M
9
$292M
10
$259M
11
$258M
12
$218M
13
$215M
14
$191M
15
$180M
16
$163M
17
$135M
18
$120M
19
$116M
20
$101M
21
$98.8M
22
$95.3M
23
$88.6M
24
$88.3M
25
$87.9M